[
    [
        {
            "time": "2021-04-15",
            "original_text": "Lilly and Incyte communicate review extension of supplemental New Drug Application for baricitinib for the treatment of moderate to severe atopic dermatitis",
            "features": {
                "keywords": [
                    "Lilly",
                    "Incyte",
                    "baricitinib",
                    "atopic dermatitis",
                    "New Drug Application",
                    "review extension"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Lilly and Incyne communicate review extension of supplemental New Drug Application for baricitinib for the treatment of moderate to severe atopic dermatitis",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-04-27",
            "original_text": "Lilly Confirms Date and Conference Call for First-Quarter 2021 Financial Results Announcement",
            "features": {
                "keywords": [
                    "Lilly",
                    "Financial Results",
                    "Conference Call",
                    "First-Quarter",
                    "2021"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Lilly Confirms Date and Conference Call for First-Quarter 2021 Financial Results Announcement",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        }
    ]
]